Biotechnology company claims to have 97% of human genes on its database.
作者信息
Josefson D
出版信息
West J Med. 2000 Apr;172(4):228. doi: 10.1136/ewjm.172.4.228.
Abstract
摘要
相似文献
1
Biotechnology company claims to have 97% of human genes on its database.
West J Med. 2000 Apr;172(4):228. doi: 10.1136/ewjm.172.4.228.
2
Human genome. NIH considers paying to use private database.
Science. 2001 Jan 12;291(5502):223-5. doi: 10.1126/science.291.5502.223.
3
Human genome. Storm erupts over terms for publishing Celera's sequence.
Science. 2000 Dec 15;290(5499):2042-3. doi: 10.1126/science.290.5499.2042.
4
In the crossfire: Collins on genomes, patents, and 'rivalry'. Interview by Eliot Marshall, Elizabeth Pennisi, and Leslie Roberts.
Science. 2000 Mar 31;287(5462):2396-8. doi: 10.1126/science.287.5462.2396.
5
Private vs public genomics?
Nature. 2000 Jan 13;403(6766):117. doi: 10.1038/35003001.
6
Human chromosome 22 and the virtues of collaboration.
Nature. 1999 Dec 2;402(6761):445. doi: 10.1038/44888.
7
Pricing human genes: the patent rush pushes on.
J Natl Cancer Inst. 2000 Jan 19;92(2):96-7. doi: 10.1093/jnci/92.2.96.
8
Celera turns to public genome data to speed up endgame.
Nature. 2000 Jan 13;403(6766):119. doi: 10.1038/35003269.
9
Company aims to beat NIH human genome efforts.
Nature. 1998 May 14;393(6681):101. doi: 10.1038/30057.
10
Genomic capital: public cultures and market logics of corporate biotechnology.
Sci Cult (Lond). 2003 Mar;12(1):87-121. doi: 10.1080/0950543032000062272.
Zotero 插件